JP5678045B2 - 高感度バイオマーカーパネル - Google Patents

高感度バイオマーカーパネル Download PDF

Info

Publication number
JP5678045B2
JP5678045B2 JP2012515019A JP2012515019A JP5678045B2 JP 5678045 B2 JP5678045 B2 JP 5678045B2 JP 2012515019 A JP2012515019 A JP 2012515019A JP 2012515019 A JP2012515019 A JP 2012515019A JP 5678045 B2 JP5678045 B2 JP 5678045B2
Authority
JP
Japan
Prior art keywords
marker
sample
antibody
label
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012515019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529655A (ja
JP2012529655A5 (enExample
Inventor
フィリップ・ジェイ・ゴイックス
ロバート・プスカス
ジョン・トッド
リチャード・リビングストン
ダグラス・ヘルド
サラ・リ
Original Assignee
シンギュレックス・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シンギュレックス・インコーポレイテッド filed Critical シンギュレックス・インコーポレイテッド
Publication of JP2012529655A publication Critical patent/JP2012529655A/ja
Publication of JP2012529655A5 publication Critical patent/JP2012529655A5/ja
Application granted granted Critical
Publication of JP5678045B2 publication Critical patent/JP5678045B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/32—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bacillus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
JP2012515019A 2009-06-08 2010-06-07 高感度バイオマーカーパネル Expired - Fee Related JP5678045B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18519409P 2009-06-08 2009-06-08
US61/185,194 2009-06-08
PCT/US2010/037613 WO2010144358A1 (en) 2009-06-08 2010-06-07 Highly sensitive biomarker panels

Publications (3)

Publication Number Publication Date
JP2012529655A JP2012529655A (ja) 2012-11-22
JP2012529655A5 JP2012529655A5 (enExample) 2013-07-25
JP5678045B2 true JP5678045B2 (ja) 2015-02-25

Family

ID=43309176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515019A Expired - Fee Related JP5678045B2 (ja) 2009-06-08 2010-06-07 高感度バイオマーカーパネル

Country Status (6)

Country Link
US (3) US8450069B2 (enExample)
EP (1) EP2440936A4 (enExample)
JP (1) JP5678045B2 (enExample)
AU (1) AU2010259022B2 (enExample)
CA (1) CA2762612A1 (enExample)
WO (1) WO2010144358A1 (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040305B2 (en) 2004-09-28 2015-05-26 Singulex, Inc. Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry
US8685711B2 (en) 2004-09-28 2014-04-01 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
JP5308328B2 (ja) 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド トロポニンの分析のための高感度のシステムおよび方法
CA2709217C (en) 2007-12-19 2021-01-05 Singulex, Inc. Scanning analyzer for single molecule detection and methods of use
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
EP2440936A4 (en) 2009-06-08 2013-03-13 Singulex Inc GROUPS OF HIGHLY SENSITIVE BIOMARKERS
US20120231472A1 (en) * 2009-11-07 2012-09-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BR112012032537B8 (pt) 2010-07-09 2022-10-18 Somalogic Inc Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo
WO2012021714A2 (en) * 2010-08-12 2012-02-16 William Marsh Rice University Biomarker signatures for wellness testing
MX350533B (es) 2010-08-13 2017-09-08 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
WO2012095507A1 (en) * 2011-01-13 2012-07-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for predicting the risk of having a cardiovascular event in a subject
JP5673955B2 (ja) * 2011-09-27 2015-02-18 株式会社島津製作所 分光蛍光光度計
US20140315742A1 (en) 2011-09-29 2014-10-23 Meso Scale Technologies, Llc Biodosimetry panels and methods
SG10201607331WA (en) * 2011-09-30 2016-11-29 Somalogic Inc Cardiovascular risk event prediction and uses thereof
AU2015249162B2 (en) * 2011-09-30 2018-01-04 Somalogic Operating Co., Inc. Cardiovascular risk event prediction and uses thereof
EP2508890A1 (en) * 2011-10-25 2012-10-10 Roche Diagnostics GmbH CAIX based diagnosis of heart failure
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
SG11201407569PA (en) * 2012-05-22 2014-12-30 Berg Llc Interrogatory cell-based assays for identifying drug-induced toxicity markers
CN107255721A (zh) 2012-09-12 2017-10-17 博格有限责任公司 标志物用于识别心脏毒性剂的用途
GB201220573D0 (en) * 2012-11-15 2013-01-02 Univ Central Lancashire Methods of diagnosing proliferative disorders
US20140329721A1 (en) * 2013-01-03 2014-11-06 Meso Scale Technologies, Llc Assay panels
WO2014127265A1 (en) * 2013-02-14 2014-08-21 Singulex, Inc. Non-invasive methods to determine vulnerable plaque burden in subjects
ES2804300T3 (es) * 2013-03-12 2021-02-05 Ventana Med Syst Inc Microscopía mejorada digitalmente para histología multiplexada
JP6671276B2 (ja) 2013-03-27 2020-03-25 セダーズ−シナイ メディカル センター Ｔｌ１ａ機能および関連するシグナル経路の抑制による線維症および炎症の緩和および回復
RU2718647C2 (ru) * 2013-04-26 2020-04-10 Конинклейке Филипс Н.В. Медицинский прогноз и предсказание результатов лечения, используя активности множества клеточных сигнальных путей
WO2015009970A1 (en) 2013-07-18 2015-01-22 Erythron Llc Spectroscopic measurements with parallel array detector
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
MX2016002879A (es) * 2013-09-06 2016-08-17 Cedars Sinai Medical Center Sistemas, dispositivos y metodos para la terapia anti-tl1a.
US20160340737A1 (en) * 2014-01-29 2016-11-24 Albert Einstein College Of Medicine, Inc. Epigenetic stem cell commitment-associated signature
WO2015131151A2 (en) 2014-02-28 2015-09-03 Erythron, Llc Method and apparatus for determining markers of health by analysis of blood
US9662073B2 (en) * 2014-03-07 2017-05-30 Cardiac Pacemakers, Inc. Heart failure event detection using multi-level categorical fusion
WO2015142808A1 (en) * 2014-03-17 2015-09-24 Arizona Board Of Regents On Behalf Of Arizona State University System and method for measuring artery thickness using ultrasound imaging
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
AU2014407088B2 (en) 2014-09-26 2021-09-23 Somalogic Operating Co., Inc. Cardiovascular risk event prediction and uses thereof
EP3210016A1 (en) 2014-10-20 2017-08-30 Nestec S.A. Methods for prediction of anti-tnf alpha drug levels and autoantibody formation
CN104630341B (zh) * 2014-11-24 2017-12-05 吉林大学 中国西门塔尔牛fgf‑1基因作胴体肉品质的遗传标记
CA2969326A1 (en) 2014-12-02 2016-06-09 Nestec S.A. Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
WO2016168090A1 (en) 2015-04-14 2016-10-20 Nueon, Inc. Method and apparatus for determining markers of health by analysis of blood
CN114441773A (zh) * 2016-02-01 2022-05-06 普雷西奥公司 用于心血管疾病和事件的诊断和预后方法
EP3430172A4 (en) 2016-03-17 2019-08-21 Cedars-Sinai Medical Center METHOD FOR DIAGNOSIS OF INFLAMMATORY ENDURANCE THROUGH RNASET2
WO2017165403A1 (en) 2016-03-21 2017-09-28 Nueon Inc. Porous mesh spectrometry methods and apparatus
WO2018085699A1 (en) 2016-11-04 2018-05-11 Nueon Inc. Combination blood lancet and analyzer
US12130290B2 (en) 2016-11-29 2024-10-29 Trustees Of Tufts College Compositions and methods for diagnosing breast cancer
JP7328960B2 (ja) 2017-10-10 2023-08-17 プロメテウス バイオサイエンシーズ インコーポレイテッド ベドリズマブ処置をモニタリングするための方法
US20190259482A1 (en) * 2018-02-20 2019-08-22 Mediedu Oy System and method of determining a prescription for a patient
CN113260863A (zh) * 2018-08-17 2021-08-13 豪夫迈·罗氏有限公司 用于心房纤颤的评价中的循环bmp10 (骨形态发生蛋白10)
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
CA3133234A1 (en) * 2019-03-13 2020-09-17 Crescendo Bioscience, Inc. Methods for cardiovascular disease in rheumatoid arthritis
US11567068B2 (en) * 2019-03-28 2023-01-31 Autonomous Medical Devices Inc. Detection of cardiac troponin or biological markers via shear horizontal surface acoustic wave biosensor using a wet-dry bioanalytical technique
US20230003719A1 (en) * 2019-12-13 2023-01-05 Janssen Biotech, Inc. Materials and methods for inflammatory molecular markers
US12504429B2 (en) 2020-02-03 2025-12-23 Hadasit Medical Research Services And Development Ltd. Diagnosis of congenital cytomegalovirus infection
IL295233A (en) * 2020-02-03 2022-10-01 Hadasit Med Res Service Translation: diagnosis of congenital cytomegalovirus infection
KR102334303B1 (ko) * 2020-05-06 2021-12-01 건국대학교 산학협력단 당뇨병성 황반부종에 대한 혈액내 바이오마커 및 이의 용도
CN113804894A (zh) * 2020-06-17 2021-12-17 首都医科大学附属北京世纪坛医院 尿液肿瘤坏死因子受体超家族成员19l及其多肽片段在烧伤中的应用
WO2022006470A1 (en) 2020-07-01 2022-01-06 Vanderbilt University Methods of treatment for a kidney disease
WO2022101937A1 (en) * 2020-11-12 2022-05-19 Shah Komal An integrated health data capture and analysis based device for evaluation, diagnosis and prognosis of heart failure
JP2024534348A (ja) 2021-09-09 2024-09-20 アルツパス， インコーポレイテッド ホスホ－タウ抗体および使用の方法
CN114836542A (zh) * 2022-05-30 2022-08-02 南方科技大学 一种神经内分泌肿瘤生物标志物在制备神经内分泌肿瘤诊断试剂中的应用
CN116298306A (zh) * 2023-01-10 2023-06-23 上海市第十人民医院 Gas6蛋白作为心力衰竭心室重构、病情严重性及预后诊断标志物的应用
CN116223818B (zh) * 2023-05-09 2023-07-21 四川大学华西医院 Dr3蛋白检测试剂在制备筛查aecopd的试剂盒的用途及筛查aecopd的试剂盒
CN116953254B (zh) * 2023-07-25 2025-10-10 中国人民解放军空军军医大学 早期预测微波电磁辐射对精液质量损伤的血清分子标志物

Family Cites Families (269)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071298A (en) * 1974-06-27 1978-01-31 Stanford Research Institute Laser Raman/fluorescent device for analyzing airborne particles
DE2732272C2 (de) * 1977-07-16 1979-07-05 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, 6900 Heidelberg Verfahren und Vorrichtung zur Fluoreszenzanalyse von gefärbten Partikeln, insbesondere biologischen Zellen
US4251733A (en) * 1978-06-29 1981-02-17 Hirleman Jr Edwin D Technique for simultaneous particle size and velocity measurement
US4172227A (en) * 1978-07-21 1979-10-23 Becton, Dickinson And Company Flow microfluorometer
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4521733A (en) * 1983-05-23 1985-06-04 General Electric Company NMR Imaging of the transverse relaxation time using multiple spin echo sequences
US4768879A (en) * 1986-06-17 1988-09-06 The Dow Chemical Company Method for measuring the size of objects in a fluid medium
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US4988191A (en) 1987-03-09 1991-01-29 University Of Illinois Electro-optical method and system for determining the direction of motion in double-exposure velocimetry by shifting an optical image field
US5041733A (en) * 1987-03-20 1991-08-20 Agency Of Industrial Science & Technology Method and apparatus for identifying chromosomes or cells
DE3720844A1 (de) 1987-06-24 1989-01-05 Stefan Miltenyi Trennsaeule fuer die magnetische separierung von zellen, zellaggregaten, und zellulaeren bestandteilen
US4793705A (en) * 1987-10-07 1988-12-27 The United States Of America As Represented By The United States Department Of Energy Single molecule tracking
JP2807474B2 (ja) 1987-11-02 1998-10-08 武田薬品工業株式会社 Ｄｎａおよびその用途
EP0331100A1 (en) 1988-03-02 1989-09-06 Takeda Chemical Industries, Ltd. Anti-endothelin antibodies and their use
US4927265A (en) * 1988-04-29 1990-05-22 501 Microphoretic Systems, Inc. Detector for fluorescence and absorption spectroscopy
US5155581A (en) * 1988-05-06 1992-10-13 Minolta Camera Kabushiki Kaisha Electronic still video camera
US5231166A (en) 1988-10-25 1993-07-27 Takeda Chemical Industries, Ltd. Endothelin
US5002389A (en) * 1988-12-22 1991-03-26 Honeywell Inc. Pulsed fluorescence velocimeter
US5385707A (en) * 1988-12-28 1995-01-31 Stefan Miltenyi Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
US4979824A (en) * 1989-05-26 1990-12-25 Board Of Trustees Of The Leland Stanford Junior University High sensitivity fluorescent single particle and single molecule detection apparatus and method
US5108179A (en) * 1989-08-09 1992-04-28 Myers Stephen A System and method for determining changes in fluorescence of stained nucleic acid in electrophoretically separated bands
US5274240A (en) * 1990-01-12 1993-12-28 The Regents Of The University Of California Capillary array confocal fluorescence scanner and method
US5770029A (en) * 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
CA2079005A1 (en) * 1990-04-11 1991-10-12 Geoffrey Stephen Begg Methods and apparatus allowing sequential chemical reactions
US5094594A (en) * 1990-04-23 1992-03-10 Genomyx, Incorporated Piezoelectric pumping device
US5230997A (en) * 1990-07-19 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting the presence of human herpesvirus-7 infection
US5269937A (en) * 1990-10-23 1993-12-14 Cetus Corporation HPLC light scattering detector for biopolymers
ES2089256T3 (es) 1991-02-15 1996-10-01 Takeda Chemical Industries Ltd Antagonista de la endotelina.
US5366859A (en) 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5846708A (en) * 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US5290834A (en) * 1991-12-04 1994-03-01 Rohm & Haas Company Method for controlling elution rate of agent
US5209834A (en) * 1992-03-09 1993-05-11 The United States Of America As Represented By The United States Department Of Energy Ordered transport and identification of particles
JP3517241B2 (ja) * 1993-01-18 2004-04-12 エボテック バイオシステムズ アクチェン ゲゼルシャフト 生体高分子の適応度を評価するための方法および装置
GB9301122D0 (en) * 1993-01-21 1993-03-10 Scient Generics Ltd Method of analysis/separation
US5547849A (en) * 1993-02-17 1996-08-20 Biometric Imaging, Inc. Apparatus and method for volumetric capillary cytometry
JPH06265447A (ja) * 1993-03-16 1994-09-22 Hitachi Ltd 微量反応装置およびこれを使用する微量成分測定装置
US5543838A (en) * 1993-08-31 1996-08-06 Xerox Corporation Signal multiplexing system for an image sensor array
KR950008684A (ko) 1993-09-21 1995-04-19 쇼다 오사무 아포리포프로틴 b로 이루어진 엔도텔린 전환효소
JP3290786B2 (ja) * 1993-11-26 2002-06-10 シスメックス株式会社 粒子分析装置
DE4405005A1 (de) * 1994-02-17 1995-08-24 Rossendorf Forschzent Mikro-Fluiddiode
US5540494A (en) * 1994-06-03 1996-07-30 Purvis, Jr.; Norman B. Method and apparatus for determining absolute particle size, surface area and volume normalized fluorescence using forward angle light scatter intensity in flow cytometry
US6001229A (en) * 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
US5658413A (en) * 1994-10-19 1997-08-19 Hewlett-Packard Company Miniaturized planar columns in novel support media for liquid phase analysis
US5571410A (en) * 1994-10-19 1996-11-05 Hewlett Packard Company Fully integrated miniaturized planar liquid sample handling and analysis device
US5645702A (en) * 1995-06-07 1997-07-08 Hewlett-Packard Company Low voltage miniaturized column analytical apparatus and method
US5603351A (en) * 1995-06-07 1997-02-18 David Sarnoff Research Center, Inc. Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
FI98765C (fi) * 1995-01-16 1997-08-11 Erkki Soini Virtaussytometrinen menetelmä ja laite
DE19508366C2 (de) * 1995-03-10 1998-01-29 Evotec Biosystems Gmbh Verfahren zum direkten Nachweisen weniger Nucleinsäurestränge
US5793485A (en) * 1995-03-20 1998-08-11 Sandia Corporation Resonant-cavity apparatus for cytometry or particle analysis
US5682038A (en) * 1995-04-06 1997-10-28 Becton Dickinson And Company Fluorescent-particle analyzer with timing alignment for analog pulse subtraction of fluorescent pulses arising from different excitation locations
US6991907B1 (en) 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
US5798222A (en) * 1995-07-17 1998-08-25 Guava Technologies, Inc. Apparatus for monitoring substances in organisms
US6132580A (en) * 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US5716825A (en) * 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
DE19548028A1 (de) * 1995-12-21 1997-06-26 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Sandwich-Immunoassays, bestehend aus einem Antikörper gegen einen der im Assay benutzten Antikörper und einer Sequenz des Analyten
US5746901A (en) * 1996-04-05 1998-05-05 Regents Of The University Of California Hybrid slab-microchannel gel electrophoresis system
US6399023B1 (en) * 1996-04-16 2002-06-04 Caliper Technologies Corp. Analytical system and method
US5795758A (en) * 1997-04-18 1998-08-18 Smithkline Beecham Corporation DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
US5863801A (en) * 1996-06-14 1999-01-26 Sarnoff Corporation Automated nucleic acid isolation
DE19630956A1 (de) * 1996-07-31 1998-02-05 Basf Ag Verfahren und Vorrichtung zur Raman-Korrelationsspektroskopie
DE19634873A1 (de) * 1996-08-29 1998-03-12 Boehringer Mannheim Gmbh System zur Unterscheidung fluoreszierender Molekülgruppen durch zeitaufgelöste Fluoreszenzmessung
US6131101A (en) 1996-11-14 2000-10-10 Melissa Data Corp. Electronic processing of mailing lists
DE19647927A1 (de) * 1996-11-20 1998-05-28 Bayer Ag Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
DE19649048C1 (de) * 1996-11-27 1998-04-09 Evotec Biosystems Gmbh Verfahren zur Unterscheidung oder Erfassung von Partikeln in einer Probe durch Identifizierung von Signalabschnitten zeitaufgelöster, optischer Rohsignale aus der Probe auf Basis von Einzelphotonendetektion
US5795158A (en) * 1996-12-02 1998-08-18 Warinner; Peter Apparatus to review clinical microbiology
CA2281205A1 (en) * 1997-02-12 1998-08-13 Eugene Y. Chan Methods and products for analyzing polymers
CA2284870C (en) * 1997-03-17 2003-11-25 Tsi Incorporated System for detecting fluorescing components in aerosols
US6235471B1 (en) * 1997-04-04 2001-05-22 Caliper Technologies Corp. Closed-loop biochemical analyzers
US5985214A (en) * 1997-05-16 1999-11-16 Aurora Biosciences Corporation Systems and methods for rapidly identifying useful chemicals in liquid samples
US6710871B1 (en) * 1997-06-09 2004-03-23 Guava Technologies, Inc. Method and apparatus for detecting microparticles in fluid samples
GB2326229A (en) * 1997-06-13 1998-12-16 Robert Jeffrey Geddes Carr Detecting and analysing submicron particles
US5989402A (en) * 1997-08-29 1999-11-23 Caliper Technologies Corp. Controller/detector interfaces for microfluidic systems
US6130101A (en) * 1997-09-23 2000-10-10 Molecular Probes, Inc. Sulfonated xanthene derivatives
US6143152A (en) 1997-11-07 2000-11-07 The Regents Of The University Of California Microfabricated capillary array electrophoresis device and method
US6049380A (en) * 1997-11-12 2000-04-11 Regents Of The University Of California Single molecule identification using selected fluorescence characteristics
JP2000516345A (ja) 1997-11-18 2000-12-05 バイオ―ラッド ラボラトリーズ インコーポレイテッド 固相として磁性粒子を用いる多重フロー免疫検定
US6041515A (en) * 1998-01-12 2000-03-28 Life Technologies, Inc. Apparatus for drying solutions containing macromolecules
SE9800360D0 (sv) * 1998-02-06 1998-02-06 Goeteborg University Science I Method, apparatus and flow cell for high sensitivity detection of fluorescent molecules
DE19822452C2 (de) 1998-04-22 2003-02-13 Stefan Seeger Verfahren zur Bestimmung der Dichte lumineszierender Moleküle an einer Oberfläche, Verwendung des Verfahrens zur Bestimmung von Adsorptions- und Bindungskinetiken und Gleichgewichts- und Bindungskonstanten von Molekülen an einer Oberfläche durch Lumineszenz-Messungen und Vorrichtung zur Durchführung des Verfahrens
EP0955084B1 (en) 1998-04-27 2006-07-26 Corning Incorporated Method of depositing an array of biological samples using a redrawn capillary reservoir
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6689323B2 (en) 1998-10-30 2004-02-10 Agilent Technologies Method and apparatus for liquid transfer
US6361671B1 (en) * 1999-01-11 2002-03-26 The Regents Of The University Of California Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels
JP2000208208A (ja) * 1999-01-18 2000-07-28 Sony Corp コネクタ装置及びそれを用いた電子機器並びにプラグ
US6473176B2 (en) * 1999-01-25 2002-10-29 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6671044B2 (en) * 1999-01-25 2003-12-30 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells in broad flat flow
US6249341B1 (en) * 1999-01-25 2001-06-19 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
DE19909326A1 (de) * 1999-03-03 2000-09-21 Lucas Ind Plc Vorrichtung und Verfahren zum Steuern der Fahrgeschwindigkeit eines Kraftfahrzeuges
US6821249B2 (en) 1999-03-08 2004-11-23 Board Of Regents, The University Of Texas Temperature monitoring of congestive heart failure patients as an indicator of worsening condition
ES2296613T3 (es) 1999-03-18 2008-05-01 Queen Mary And Westfield College Inhibidores de la sintesis de endotelina-1.
WO2000055882A1 (en) * 1999-03-18 2000-09-21 Cambridge Research & Instrumentation Inc. High-efficiency multiple probe imaging system
US6242266B1 (en) * 1999-04-30 2001-06-05 Agilent Technologies Inc. Preparation of biopolymer arrays
AU770678B2 (en) * 1999-05-17 2004-02-26 Caliper Life Sciences, Inc. Focusing of microparticles in microfluidic systems
US6309886B1 (en) * 1999-06-04 2001-10-30 The Regents Of The University Of California High throughput analysis of samples in flowing liquid
US6811668B1 (en) 1999-06-22 2004-11-02 Caliper Life Sciences, Inc. Apparatus for the operation of a microfluidic device
US6338746B1 (en) * 1999-07-23 2002-01-15 Rlc Technologies, L.L.C. Polymer-sulfur-polymer coated fertilizers
US6532067B1 (en) * 1999-08-09 2003-03-11 The United States Of America As Represented By The Secretary Of The Army Aerosol fluorescence spectrum analyzer for rapid measurement of single airborne particles
US6495104B1 (en) * 1999-08-19 2002-12-17 Caliper Technologies Corp. Indicator components for microfluidic systems
US7654998B1 (en) 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
WO2002037096A1 (en) 1999-10-01 2002-05-10 University Of California Microfabricated liquid sample loading system
JP5043253B2 (ja) 1999-10-21 2012-10-10 花王株式会社 脱毛剤及び外用剤
AU784618B2 (en) 1999-12-28 2006-05-18 Kyowa Hakko Kogyo Co. Ltd. Cells capable of differentiating into heart muscle cells
AU1055201A (en) 1999-12-28 2001-07-09 Kyowa Hakko Kogyo Co. Ltd. Cells capable of differentiating into heart muscle cells
DE10019058A1 (de) 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US6296452B1 (en) * 2000-04-28 2001-10-02 Agilent Technologies, Inc. Microfluidic pumping
WO2001090748A2 (en) * 2000-05-19 2001-11-29 Iowa State University Research Foundation, Inc. High-throughput methods of distinguishing at least one molecule individually in a sample comprising multiple molecules and systems for use therein
AU2001275530A1 (en) 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Inhibitors of c-reactive protein induced inflammation
US6608680B2 (en) 2000-08-25 2003-08-19 Amnis Corporation TDI imaging system for kinetic studies
AUPR005600A0 (en) 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
DE01975541T9 (de) 2000-09-29 2006-11-16 Molecular Probes, Inc., Eugene Modifizierte carbocyaninfarbstoffe und deren konjugate
US20040029140A1 (en) 2000-10-04 2004-02-12 Anderson David W. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6537437B1 (en) * 2000-11-13 2003-03-25 Sandia Corporation Surface-micromachined microfluidic devices
WO2002046465A2 (en) 2000-12-08 2002-06-13 Oxford Biomedica (Uk) Limited Method for identification of genes involved in specific diseases
US6783992B2 (en) 2001-01-03 2004-08-31 Agilent Technologies, Inc. Methods and using chemico-mechanical microvalve devices for the selective separation of components from multi-component fluid samples
EP1221678A1 (fr) 2001-01-09 2002-07-10 Telectronic SA Récepteur destiné à capter un signal électromagnétique et dispositif utilisant un tel récepteur
US6850317B2 (en) * 2001-01-23 2005-02-01 Schlumberger Technology Corporation Apparatus and methods for determining velocity of oil in a flow stream
US6386219B1 (en) * 2001-02-01 2002-05-14 Agilent Technologies, Inc. Fluid handling system and method of manufacture
JP2004531249A (ja) 2001-02-14 2004-10-14 プロテイン デザイン ラブス インコーポレイティド 血管新生の診断方法、組成物、及び血管新生モジュレータのスクリーニング方法
US6949377B2 (en) * 2001-03-05 2005-09-27 Ho Winston Z Chemiluminescence-based microfluidic biochip
US6802342B2 (en) 2001-04-06 2004-10-12 Fluidigm Corporation Microfabricated fluidic circuit elements and applications
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
JP3806694B2 (ja) * 2001-05-04 2006-08-09 バイオサイト インコーポレイテッド 急性冠状動脈症候群の診断マーカーおよびその使用方法
US7076092B2 (en) 2001-06-14 2006-07-11 The United States Of America As Represented By The United States Department Of Energy High-throughput, dual probe biological assays based on single molecule detection
US6766817B2 (en) 2001-07-25 2004-07-27 Tubarc Technologies, Llc Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action
US20040033495A1 (en) 2001-08-03 2004-02-19 Eos Biotechnology, Inc. Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
WO2003016475A2 (en) 2001-08-14 2003-02-27 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
US20040219509A1 (en) 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6394305B1 (en) * 2001-08-31 2002-05-28 Beverly Sydlosky Food holder and lifter with adjustable handles
US20040191774A1 (en) 2001-09-11 2004-09-30 Moskowitz David W Endothelin-1 promoter polymorphism
JP2005525787A (ja) 2001-10-24 2005-09-02 シンギュレックス・インコーポレイテッド プローブとの相互作用による遺伝子ハプロタイプの検出方法
US6867005B2 (en) * 2001-10-24 2005-03-15 Beckman Coulter, Inc. Method and apparatus for increasing the dynamic range and accuracy of binding assays
US6599436B1 (en) 2001-12-06 2003-07-29 Sandia Corporation Formation of interconnections to microfluidic devices
US20030143544A1 (en) 2002-01-09 2003-07-31 Vitivity, Inc. Diagnosis and treatment of vascular disease
US20030139333A1 (en) 2002-01-18 2003-07-24 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis
US20050250202A1 (en) 2002-03-19 2005-11-10 March Keith L Adipose stromal stem cells for tissue and vascular modification
WO2004000997A2 (en) 2002-03-19 2003-12-31 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
RS89204A (sr) 2002-04-10 2006-12-15 Applied Research Systems Ars Holding N.V. Upotreba osteoprotegerina za lečenje i/ili prevenciju fibrozne bolesti
WO2003088294A2 (en) 2002-04-11 2003-10-23 Bristol-Myers Squibb Company Mass spectrometer autosampler
WO2003088980A1 (en) 2002-04-18 2003-10-30 Embury Stephen H Method and composition for preventing pain in sickle cell patients
MXPA03004105A (es) * 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
US20070225614A1 (en) * 2004-05-26 2007-09-27 Endothelix, Inc. Method and apparatus for determining vascular health conditions
JP2004097086A (ja) 2002-09-09 2004-04-02 National Cardiovascular Center エンドセリン１遺伝子中の多型を利用した高血圧症の遺伝子診断およびこれに用いるための核酸分子
US20040146907A1 (en) 2002-11-13 2004-07-29 Genentech, Inc. Methods and compositions for detecting dysplasia
EP1962096B1 (de) 2002-11-16 2012-07-18 Siemens Healthcare Diagnostics Products GmbH SCD40L, PAPP-A und plazentaler-Wachstumsfaktor (PIGF) als biochemische Markerkombination bei kardiovaskulären Erkrankungen
AU2003298672A1 (en) 2002-11-19 2005-01-28 Singulex, Inc. Detection of target molecules through interaction with probes
ATE335763T1 (de) 2002-11-20 2006-09-15 Brahms Ag Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
EP2151507B1 (en) 2002-12-20 2013-02-13 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
JP2009519001A (ja) 2002-12-20 2009-05-14 アプレラ コーポレイション 狭窄に関連する遺伝的多型、その検出方法および使用
CA2511501A1 (en) 2002-12-24 2004-07-15 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
EP1587424A4 (en) 2002-12-31 2012-01-25 Marinepolymer Tech Inc Bleeding Compounds and their uses
JP2006520463A (ja) 2003-01-23 2006-09-07 ユー．エス． ジェノミクス， インコーポレイテッド ポリマー集団を解析するための方法
JP2004313168A (ja) 2003-02-24 2004-11-11 National Cardiovascular Center 降圧薬への感受性の遺伝子診断に用いることができる核酸分子
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
FI20030652A0 (fi) 2003-04-30 2003-04-30 Susann Eriksson Parannettu immunomääritys
US7074194B2 (en) 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
US20050008710A1 (en) 2003-07-09 2005-01-13 Phytomyco Research Corporation Method for screening for endothelin-receptor antagonist activity and for treating conditions caused by endothelin
US7547518B2 (en) 2003-08-19 2009-06-16 Becton, Dickinson And Company Method of screening endothelial cells for angiogenic capability
US20050106100A1 (en) 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20070092888A1 (en) 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US7392140B2 (en) 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20050181386A1 (en) 2003-09-23 2005-08-18 Cornelius Diamond Diagnostic markers of cardiovascular illness and methods of use thereof
US20080010024A1 (en) 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
JP2007533971A (ja) 2003-09-30 2007-11-22 シンギュレックス・インコーポレイテッド 粒子検出の分析精度を改善する方法
EP1530047A1 (en) 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
EP1692506A4 (en) 2003-11-17 2008-01-09 Janssen Pharmaceutica Nv MODELING A SYSTEMIC INFLAMMATORY RESPONSE TO INFECTION
WO2005056837A2 (en) 2003-11-26 2005-06-23 Applera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7332569B2 (en) 2004-01-27 2008-02-19 Compugen Ltd. Brain natriuretic peptide spliced variant
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US8182990B2 (en) 2004-03-18 2012-05-22 Rusk Intellectual Reserve Ag Method for diagnosing or predicting susceptibility to optic neuropathy
EP1756583B1 (en) 2004-03-19 2010-10-27 Biomedica Medizinprodukte GmbH & Co KG Prognostic methods for congestive heart failure
JP2007529758A (ja) 2004-03-19 2007-10-25 ユー．エス． ジェノミクス， インコーポレイテッド 単一分子の検出のための組成物および方法
EP3070174B1 (en) 2004-05-11 2019-11-06 Ncardia AG Drug discovery based on in vitro differentiated cells
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
JP2008505649A (ja) 2004-07-09 2008-02-28 アモークス リミテッド 免疫細胞バイオセンサーおよびその使用方法
EP1619505B1 (en) 2004-07-22 2008-04-16 BRAHMS Aktiengesellschaft Method for the diagnosis of critically ill patients
US7828711B2 (en) 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US7351538B2 (en) 2004-08-23 2008-04-01 U.S. Genomics Systems and methods for detecting and analyzing polymers
JP2008514955A (ja) 2004-09-28 2008-05-08 シンギュレックス・インコーポレイテッド サンプル分析システムおよび方法
US8685711B2 (en) 2004-09-28 2014-04-01 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
US9040305B2 (en) 2004-09-28 2015-05-26 Singulex, Inc. Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry
WO2006098772A2 (en) 2004-10-13 2006-09-21 U.S. Genomics, Inc. Systems and methods for measurement optimization
EP2194144B1 (en) 2004-11-16 2015-01-07 Trustees of Boston University Anti-Dual Endothelin-1/Angiotensin II receptor (DEAR) antibody for inhibiting disease-associated or pathological angiogenesis.
GB0521621D0 (en) 2005-10-24 2005-11-30 Domantis Ltd Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
DE602006017071D1 (de) 2005-01-25 2010-11-04 Five Prime Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
JP2006339516A (ja) 2005-06-03 2006-12-14 Rohm Co Ltd 半導体装置およびその製造方法
JP2008544224A (ja) 2005-06-09 2008-12-04 バイオサイト インコーポレイテッド 静脈血栓塞栓症の診断のための方法および組成物
US7482124B2 (en) 2005-07-08 2009-01-27 Bristol-Myers Squibb Company Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
DE102005036094A1 (de) 2005-08-01 2007-02-08 B.R.A.H.M.S Ag In vitro Verfahren zur Diagnose von neurodegenerativen Erkrankungen
CA2623523C (en) 2005-09-28 2019-02-12 Becton, Dickinson And Company Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
AU2006299417A1 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
US20070259377A1 (en) 2005-10-11 2007-11-08 Mickey Urdea Diabetes-associated markers and methods of use thereof
US8906857B2 (en) 2005-12-01 2014-12-09 B.R.A.H.M.S. Gmbh Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
JP4976412B2 (ja) 2005-12-01 2012-07-18 ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー エンドセリン、エンドセリンアゴニスト及びアドレノメジュリンアンタゴニストによる危篤患者の診断及び治療のための方法
CA2638819A1 (en) 2006-02-10 2008-04-03 Zymogenetics, Inc. Soluble il-17rcx4 and methods of using in inflammation
AU2007230887A1 (en) 2006-03-23 2007-10-04 Amylin Pharmaceuticals, Inc. Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
JP5308328B2 (ja) * 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド トロポニンの分析のための高感度のシステムおよび方法
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US20090104615A1 (en) 2006-05-02 2009-04-23 Keith Malcolm Godfrey Phenotype prediction
DE102006023175A1 (de) 2006-05-17 2007-11-22 B.R.A.H.M.S Aktiengesellschaft In vitro Verfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen
EP2924440A3 (en) 2006-06-07 2016-03-09 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
DE102006027818A1 (de) 2006-06-16 2007-12-20 B.R.A.H.M.S. Aktiengesellschaft In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
EP1887361A1 (en) 2006-08-07 2008-02-13 Bio-Rad Pasteur Method for the prediction of vascular events
EP1890153A1 (en) * 2006-08-16 2008-02-20 F. Hoffman-la Roche AG Cardiac troponin as an indicator of advanced coronary artery disease
US20080090242A1 (en) 2006-09-29 2008-04-17 Schering Corporation Panel of biomarkers for prediction of fti efficacy
DE102006052916A1 (de) 2006-11-08 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
US9012151B2 (en) 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
US7960110B2 (en) 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
DE102006062398A1 (de) 2006-12-20 2008-06-26 Edi (Experimentelle & Diagnostische Immunologie) Gmbh Verfahren zur Erkennung und/oder Charakterisierung zellulärer Aktivitätsmuster, Verwendung von Toll-like-Rezeptor-Liganden (TLR-Liganden) und ein Kit
DE102006060835A1 (de) 2006-12-22 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP
US8075902B2 (en) 2007-01-03 2011-12-13 Michael Powell Diagnosis and treatment of cancer related to human dormancy
US20100120628A1 (en) 2007-02-06 2010-05-13 Genizon Biosciences Inc. Genemap of the human genes associated with adhd
DE102007010834A1 (de) 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten
US9289426B2 (en) 2007-03-21 2016-03-22 University Of Pennsylvania Methods and compositions for treating solid tumors and enhancing tumor vaccines
US20080300798A1 (en) * 2007-04-16 2008-12-04 Mcdevitt John T Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
DE102007021443A1 (de) 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1
GB0724331D0 (en) 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
DE102007029766A1 (de) 2007-06-22 2008-12-24 Brahms Aktiengesellschaft Verfahren zur Detektion von Analyten
CN101896816B (zh) 2007-06-22 2014-08-20 B.R.A.H.M.S有限公司 用于检测分析物的方法
US9062347B2 (en) 2007-07-27 2015-06-23 The Regents Of The University Of Colorado, A Body Corporate Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy
WO2009054996A2 (en) 2007-10-25 2009-04-30 Genelux Corporation Systems and methods for viral therapy
WO2009061456A2 (en) 2007-11-07 2009-05-14 University Of Houston Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
US8598311B2 (en) 2007-11-21 2013-12-03 The University Of The Sciences In Philadelphia Complexation of fatty acid-conjugated molecules with albumin
US20090176312A1 (en) 2007-12-04 2009-07-09 Selinfreund Richard H Biological and chemical test media and system
US20100260853A1 (en) 2007-12-13 2010-10-14 Amrik Basran Compositions for pulmonary delivery
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
ES2552816T3 (es) 2008-02-01 2015-12-02 B.R.A.H.M.S Gmbh Procedimiento para identificar pacientes con trastornos cognitivos leves que necesitan terapia y tratamiento de pacientes de este tipo
JP2011513753A (ja) * 2008-03-05 2011-04-28 シンギュレックス・インコーポレイテッド 分子の高感度検出の方法および組成物
AU2009224114B2 (en) 2008-03-12 2013-02-21 Otago Innovation Limited Biomarkers
CN101990578A (zh) 2008-04-04 2011-03-23 固德基因公司 存储稳定状态的核酸的新的皮肤取样试剂盒、通过使用该试剂盒的基因测试方法及其实践应用
EP2107377A1 (en) 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
EP2265957B1 (en) 2008-04-09 2013-07-24 B.R.A.H.M.S GmbH Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
US8476012B2 (en) 2008-04-18 2013-07-02 Genomas, Inc. Physiogenomic method for predicting metabolic and cardiovascular side effects of thiazolidinediones
EP2131200A1 (en) 2008-06-04 2009-12-09 BRAHMS Aktiengesellschaft A marker for graft failure and mortality
EP2878680B1 (en) 2008-07-09 2016-06-08 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
WO2010025393A2 (en) 2008-08-28 2010-03-04 The Regents Of The University Of California Protein biomarkers and methods for diagnosing kawasaki disease
ES2795003T3 (es) 2008-10-07 2020-11-20 Brahms Gmbh Biomarcador para la predicción de los primeros eventos adversos
EP2180322A1 (en) 2008-10-22 2010-04-28 BRAHMS Aktiengesellschaft Prognostic biomarkers for the progression of primary chronic kidney disease
ES2724478T3 (es) 2008-10-24 2019-09-11 Brahms Gmbh Pronóstico y evaluación del riesgo en pacientes con accidente cerebrovascular determinando el nivel de péptidos marcadores
CN106153943B (zh) 2008-10-31 2019-02-15 B.R.A.H.M.S有限公司 用作糖尿病预测生物标志物的精氨酸加压素激素原
JP5757873B2 (ja) 2008-10-31 2015-08-05 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝症候群、心血管疾患及び／又はインスリン耐性に関連する障害の診断、予後、モニターリング及び治療追跡のためのインビトロ方法
WO2010049180A1 (en) 2008-10-31 2010-05-06 B.R.A.H.M.S. Ag Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
ES2431358T3 (es) 2008-11-11 2013-11-26 B.R.A.H.M.S Gmbh Pronóstico y evaluación del riesgo en pacientes que padecen insuficiencia cardíaca mediante la determinación de la concentración de ADM
KR101717304B1 (ko) 2008-12-23 2017-03-16 메르크 파텐트 게엠베하 항-혈관생성 활성이 있는 저해제에 대한 바이오마커
JP5753159B2 (ja) 2009-05-05 2015-07-22 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 内皮性機能／機能不全に関連した疾患に罹患している患者の血管作動性ホルモンに基づいた層化
EP2440936A4 (en) 2009-06-08 2013-03-13 Singulex Inc GROUPS OF HIGHLY SENSITIVE BIOMARKERS
US20120149131A1 (en) 2009-08-28 2012-06-14 B.R.A.H.M.S Gmbh Procalcitonin for the prognosis of adverse events
GB0922240D0 (en) 2009-12-21 2010-02-03 Cambridge Entpr Ltd Biomarkers
AU2011213685B2 (en) 2010-02-05 2014-10-30 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR101878749B1 (ko) 2010-03-05 2018-07-17 삼성전자주식회사 표적 세포의 분리 방법 및 키트
US20110263438A1 (en) 2010-04-22 2011-10-27 Mehmet Ali Soylemez Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin
WO2011141544A1 (en) 2010-05-13 2011-11-17 Universität Zürich Discrete states for use as biomarkers
WO2011157446A1 (en) 2010-06-18 2011-12-22 B.R.A.H.M.S Gmbh Biomarkers for the prediction of incident cancer
US20130177901A1 (en) 2010-06-18 2013-07-11 Cezanne S.A.S. Markers for the prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia
US9255931B2 (en) 2010-06-24 2016-02-09 Morehouse School Of Medicine Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
EP2635904A1 (en) 2010-11-01 2013-09-11 B.R.A.H.M.S GmbH Prognosis and risk assessment of patients with non-specific complaints
JP6021021B2 (ja) 2010-11-05 2016-11-02 国立大学法人京都大学 多発性嚢胞腎の検査方法および治療剤のスクリーニング方法
US20120142089A1 (en) 2010-12-01 2012-06-07 Samsung Electronics Co., Ltd. Method of separating target cell in biological sample
JP2014521402A (ja) 2011-06-30 2014-08-28 カーディアック ペースメイカーズ， インコーポレイテッド 予測マーカデータを使用して植込み型医療デバイスのパラメータを設定するためのシステムおよび方法
TWI613215B (zh) 2012-02-22 2018-02-01 再生元醫藥公司 抗－大－內皮素－１（ｂｉｇ－ｅｔ－１）抗體及其用途
EP2657707A1 (en) 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope

Also Published As

Publication number Publication date
EP2440936A1 (en) 2012-04-18
EP2440936A4 (en) 2013-03-13
JP2012529655A (ja) 2012-11-22
US20160091497A1 (en) 2016-03-31
WO2010144358A1 (en) 2010-12-16
AU2010259022A1 (en) 2011-12-01
AU2010259022B2 (en) 2016-05-12
US20110003707A1 (en) 2011-01-06
US8450069B2 (en) 2013-05-28
US9068991B2 (en) 2015-06-30
CA2762612A1 (en) 2010-12-16
US20130261009A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
JP5678045B2 (ja) 高感度バイオマーカーパネル
US20240110870A1 (en) Methods and Compositions for Highly Sensitive Detection of Molecules
JP6001028B2 (ja) 高感度のマーカー分析および分子検出のための方法および組成物
JP2011513753A (ja) 分子の高感度検出の方法および組成物
JP6456990B2 (ja) 単一分子検出走査分析器およびその使用方法
US7572640B2 (en) Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
GB2458025A (en) Methods of detecting cardiac troponin using a single molecule detector
EP3156799B1 (en) Analyzer and method for highly sensitive detection of analytes
AU2013219225B2 (en) Methods and compositions for highly sensitive analysis of markers and detection of molecules
HK1156396A (en) Methods and compositions for highly sensitive detection of molecules

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130606

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130606

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140507

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150105

R150 Certificate of patent or registration of utility model

Ref document number: 5678045

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees